Results 41 to 50 of about 204 (131)
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study. [PDF]
Adv Ther, 2022 Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capece M, Lamberti R, Strollo F, Nefrocenter and Nyx Start-up, AMDOSDI Study Group on Injection Techniques, and ANIAD. +15 moreeuropepmc +1 more sourceThe Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study. [PDF]
Diabetes Ther, 2021 Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capace M, Lamberti R, Strollo F, AMD-OSDI Study Group
on Injection Technique, Nefrocenter Research and Nyx Start-Up Study Group. +14 moreeuropepmc +1 more sourceRole of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case-Control Study. [PDF]
Diabetes Ther, 2021 Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Strollo F, AMD-OSDI Study Group on Injection Technique, Nefrocenter Research and Nyx Start-Up. +10 moreeuropepmc +1 more sourceFirst-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry. [PDF]
Tumori, 2023 Galli L, Chiuri VE, Di Lorenzo G, Pisconti S, Rossetti S, Sirotova Z, Muto A, Petrioli R, De Tursi M, Sbrana A, Francolini G, Ardizzoia A, Scavelli C, Satta F, Quadrini S, Airoldi M, D'Aniello C, Bonetti A, Conforti S, Aieta M, Beccaglia P, Maestri A, Fratino L. +22 moreeuropepmc +1 more sourceConcomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis. [PDF]
Clin Pharmacol TherTursi A, Pasta A, Elisei W, Barberio B, Mocci G, Maconi G, Gravina AG, Pellegrino R, Bodini G, Savarino EV, Papa A, Italian Network for Inflammatory Bowel Diseases (IN‐IBD). +11 moreeuropepmc +1 more sourceComparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study. [PDF]
Adv TherTursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A, Italian Network for Inflammatory Bowel Diseases (IN-IBD). +62 moreeuropepmc +1 more sourceFilgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study. [PDF]
Intest ResTursi A, Mocci G, Costa F, Ceccarelli L, Savarino E, De Barba C, Mucherino C, D'Antonio E, Montesano L, Marzo M, Scaldaferri F, Napolitano D, Pugliese D, Gravina AG, Pellegrino R, Spagnuolo R, Luzza F, Cuomo A, Donnarumma L, Maconi G, Cataletti G, Bertani L, Bodini G, Pasta A, Piergallini S, Serio M, Scarcelli A, Capone P, Cortellini F, Rodino S, Sebkova L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Gaiani F, Kayali S, Pagnini C, Graziani MG, Di Paolo MC, Allegretta L, Cazzato AI, Scorza S, Ferronato A, Ribaldone DG, Aragona G, Perazzo P, Forti G, Di Fonzo M, Iacopini F, Pica R, Cassieri C, Onidi FM, Usai Satta P, Elisei W, Picchio M, Papa A. +56 moreeuropepmc +1 more source